Home Data Calendar Blog

CUE

Tables

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Common Stock Value 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02

Earnings Per Share Basic -0.29 -0.29 -0.38 -0.31 -0.37 -0.44 -0.25 -0.41 NA NA NA NA NA NA NA NA NA NA NA NA NA

Earnings Per Share Diluted -0.29 -0.29 -0.38 -0.31 -0.37 -0.44 -0.25 -0.41 NA NA NA NA NA NA NA NA NA NA NA NA NA

Earnings Per Share Basic And Diluted NA NA NA NA -0.37 -0.44 -0.25 -0.41 -0.33 -0.41 -0.36 -0.34 -0.38 -0.48 -0.36 -0.31 -0.46 -0.54 -0.58 -0.62 -0.36

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Revenue From Contract With Customer Excluding Assessed Tax 1.38 0.19 0.15 0.07 0.03 1.00 8.25 2.40 2.74 1.55 0.48 0.70 1.07 0.90 1.05 0.98 1.05 0.37 0.33 0.45 0.17

Revenues 1.38 0.19 0.15 0.07 0.03 1.00 8.25 2.40 2.74 1.55 0.48 0.70 1.07 0.90 1.05 0.98 1.05 0.37 0.33 0.45 0.17

Operating Expenses 14.90 13.57 15.02 11.10 13.12 15.24 16.15 15.41 13.04 14.07 11.45 10.84 12.02 13.89 10.06 8.08 10.29 11.80 11.30 13.21 7.64

Research And Development Expense 10.65 9.39 11.33 7.57 9.59 10.08 11.50 11.29 8.76 9.82 8.00 7.52 8.12 9.91 6.96 5.30 6.87 8.35 6.82 10.31 5.41

General And Administrative Expense 4.25 4.18 3.70 3.53 3.78 5.16 4.65 4.12 4.28 4.25 3.45 3.32 3.90 3.99 3.10 2.78 3.42 3.44 4.47 2.90 2.23

Operating Income Loss -13.52 -13.38 -14.87 -11.03 -13.09 -14.24 -7.89 -13.02 -10.30 -12.52 -10.97 -10.13 -10.94 -12.99 -9.02 -7.09 -9.23 -11.43 -10.97 -12.76 -7.47

Interest Expense 0.35 0.33 NA 0.12 0.21 0.03 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Interest Income Expense Net -0.23 -0.37 NA NA -0.21 -0.03 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Interest Paid Net 0.18 0.33 0.22 0.14 0.19 0.02 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Interest Income Expense Nonoperating Net 0.56 0.64 0.63 0.20 0.09 0.01 0.00 0.03 0.02 0.01 0.00 0.12 0.13 0.20 0.11 0.10 0.10 0.11 0.10 0.10 0.17

Allocated Share Based Compensation Expense 2.04 2.00 2.11 2.06 2.31 3.01 2.97 3.25 2.85 2.44 2.28 2.50 2.52 3.17 2.00 1.44 1.32 1.77 2.01 2.73 1.27

Profit Loss -13.19 -13.11 -14.59 -10.96 -13.21 -14.26 -8.38 -12.99 -10.28 -12.51 -11.10 -10.03 -10.83 -12.82 -8.92 -6.99 -9.52 -11.27 -11.62 -12.55 -7.29

Net Income Loss -13.19 -13.11 -14.59 -10.96 -13.21 -14.26 -8.38 -12.99 -10.28 -12.51 -11.10 -10.03 -10.83 -12.82 -8.92 -6.99 -9.52 -11.27 -11.62 -12.56 -7.30

Comprehensive Income Net Of Tax -13.15 -13.05 -14.60 -11.05 -13.21 -14.26 -8.38 -12.99 -10.28 -12.51 -11.17 -9.95 -10.93 -12.56 -8.93 -6.99 -9.52 -11.27 -11.61 -12.58 -7.30

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Assets 73.16 81.68 91.28 76.30 84.75 90.70 83.40 78.88 89.67 88.72 99.53 106.62 101.35 60.65 71.61 45.21 41.76 45.19 45.36 44.58 53.11

Liabilities 27.16 26.66 25.60 25.54 24.99 26.03 17.91 15.36 16.76 19.05 20.62 19.06 21.20 15.41 17.02 18.19 21.48 20.45 11.39 5.18 3.88

Liabilities And Stockholders Equity 73.16 81.68 91.28 76.30 84.75 90.70 83.40 78.88 89.67 88.72 99.53 106.62 101.35 60.65 71.61 45.21 41.76 45.19 45.36 44.58 53.11

Stockholders Equity 46.00 55.02 65.68 50.76 59.76 64.67 65.49 63.52 72.91 69.67 78.91 87.55 80.15 45.24 54.58 27.02 20.28 24.74 33.97 39.40 49.23

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Assets Current 60.94 68.75 77.19 61.70 69.00 75.95 68.47 70.25 79.68 77.41 87.53 93.56 88.35 51.19 61.02 32.99 29.87 31.97 40.61 40.61 49.25

Cash And Cash Equivalents At Carrying Value 52.90 56.32 51.61 29.73 66.13 67.93 64.37 67.63 73.92 73.26 74.87 71.73 59.75 23.43 44.29 31.38 24.26 21.91 20.80 15.84 45.74

Accounts Receivable Net Current 1.14 0.20 0.06 0.80 0.74 0.93 3.14 0.77 1.90 1.41 1.42 0.46 1.23 0.60 0.76 NA NA NA NA NA NA

Prepaid Expense And Other Assets Current 1.91 2.36 0.84 1.72 2.14 1.97 0.95 1.85 3.85 2.73 1.24 1.30 2.20 1.85 0.86 1.00 1.04 1.04 1.35 1.38 3.46

Available For Sale Securities Debt Securities 4.99 9.88 24.67 29.46 NA NA 0.00 NA NA NA 10.00 20.07 25.18 25.30 15.12 0.00 4.00 8.97 18.41 23.34 NA

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Property Plant And Equipment Gross 5.70 5.70 5.74 5.70 5.63 5.58 5.56 5.56 5.56 5.81 4.91 4.36 4.01 4.01 3.87 3.86 3.85 4.17 4.15 4.03 3.73

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 4.51 4.37 4.24 4.05 3.87 3.66 3.44 3.22 3.00 3.02 2.81 2.62 2.42 2.22 2.03 1.83 1.64 1.57 1.37 1.16 0.97

Property Plant And Equipment Net 1.19 1.32 1.50 1.64 1.76 1.92 2.11 2.34 2.56 2.79 2.11 1.74 1.59 1.79 1.85 2.03 2.21 2.60 2.78 2.87 2.76

Other Assets Noncurrent 0.12 0.12 0.13 0.13 0.13 0.14 0.14 0.14 0.15 0.15 0.40 0.72 0.54 0.60 0.67 0.79 0.84 0.77 0.81 NA NA

Available For Sale Debt Securities Amortized Cost Basis 4.99 9.92 24.77 29.55 NA NA NA NA NA NA 10.00 20.00 25.02 25.05 15.13 NA 4.00 8.97 18.42 23.36 NA

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Liabilities Current 16.31 13.81 11.55 10.22 8.32 11.41 12.79 15.36 16.67 16.63 16.32 14.23 14.86 12.09 11.66 10.39 11.27 10.57 6.22 4.58 2.96

Long Term Debt Current 4.00 3.00 2.00 1.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Accounts Payable Current 2.36 2.15 2.73 2.04 1.57 2.62 2.59 2.47 2.99 2.52 2.07 1.11 1.29 1.74 0.88 1.18 2.29 2.89 2.04 1.00 0.55

Accrued Liabilities Current 4.08 2.84 3.55 3.88 3.56 3.41 4.62 3.99 2.00 1.98 2.79 2.58 4.06 1.14 2.23 1.55 2.58 2.15 1.79 2.27 1.12

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Long Term Debt 6.00 7.00 8.00 9.00 9.91 9.86 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Long Term Debt Noncurrent 6.12 7.08 8.03 8.99 9.91 9.86 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Operating Lease Liability Noncurrent 4.60 5.33 6.02 6.32 6.76 4.76 5.12 NA NA 1.08 2.37 3.63 4.18 0.19 1.35 NA NA NA NA NA NA

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Stockholders Equity 46.00 55.02 65.68 50.76 59.76 64.67 65.49 63.52 72.91 69.67 78.91 87.55 80.15 45.24 54.58 27.02 20.28 24.74 33.97 39.40 49.23

Common Stock Value 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02

Additional Paid In Capital Common Stock 322.71 318.58 316.19 286.69 284.63 276.34 262.91 252.55 248.95 235.43 232.16 229.63 212.12 166.28 163.07 126.58 112.85 107.79 105.76 99.58 96.84

Retained Earnings Accumulated Deficit -276.75 -263.56 -250.46 -235.86 -224.91 -211.70 -197.45 -189.06 -176.07 -165.79 -153.29 -142.18 -132.15 -121.32 -108.50 -99.58 -92.59 -83.07 -71.80 -60.18 -47.63

Accumulated Other Comprehensive Income Loss Net Of Tax -0.01 -0.04 -0.10 -0.09 NA NA NA NA NA NA 0.01 0.07 0.15 0.25 -0.01 NA NA -0.00 -0.01 NA NA

Stock Issued During Period Value New Issues 2.02 NA NA 0.00 5.98 10.62 7.03 0.00 10.36 NA 0.00 14.33 42.35 NA 33.35 11.94 3.71 NA NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 2.04 2.00 2.11 2.06 2.31 3.01 2.97 3.25 2.85 2.44 2.28 2.50 2.52 3.17 2.00 1.44 1.32 1.77 2.01 2.74 1.27

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Net Cash Provided By Used In Operating Activities -10.37 -10.83 -10.51 -6.87 -12.85 -11.57 -10.65 -6.63 -9.77 -11.79 -7.00 -7.69 -6.86 -10.94 -6.44 -9.21 -6.68 -8.47 -3.90 -6.30 -6.46

Net Cash Provided By Used In Investing Activities 5.00 15.00 5.00 -29.52 -0.06 -0.03 0.00 -0.01 -0.23 9.35 9.89 4.65 -0.14 -9.95 -15.15 3.98 5.13 9.48 4.69 -23.61 -0.76

Net Cash Provided By Used In Financing Activities 2.10 0.39 27.40 -0.01 11.11 15.16 7.38 0.35 10.67 0.83 0.24 15.01 43.32 0.04 34.49 12.29 3.75 0.26 4.17 NA NA

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Net Cash Provided By Used In Operating Activities -10.37 -10.83 -10.51 -6.87 -12.85 -11.57 -10.65 -6.63 -9.77 -11.79 -7.00 -7.69 -6.86 -10.94 -6.44 -9.21 -6.68 -8.47 -3.90 -6.30 -6.46

Net Income Loss -13.19 -13.11 -14.59 -10.96 -13.21 -14.26 -8.38 -12.99 -10.28 -12.51 -11.10 -10.03 -10.83 -12.82 -8.92 -6.99 -9.52 -11.27 -11.62 -12.56 -7.30

Profit Loss -13.19 -13.11 -14.59 -10.96 -13.21 -14.26 -8.38 -12.99 -10.28 -12.51 -11.10 -10.03 -10.83 -12.82 -8.92 -6.99 -9.52 -11.27 -11.62 -12.55 -7.29

Increase Decrease In Accounts Receivable 0.94 0.14 -0.74 0.06 -0.19 -2.22 2.37 -1.13 0.49 -0.00 0.96 -0.77 0.62 -0.15 0.14 0.09 NA NA NA NA NA

Increase Decrease In Accounts Payable 0.20 -0.58 0.63 0.48 -1.05 0.03 0.12 -0.52 0.72 0.20 0.52 -0.18 -0.31 0.72 -0.30 -1.11 -0.60 0.86 1.04 0.45 -0.72

Share Based Compensation 2.04 2.00 2.11 2.06 2.31 3.01 2.97 3.25 2.85 2.44 2.28 2.50 2.52 3.17 2.00 1.44 1.32 1.77 2.01 2.73 1.27

Amortization Of Financing Costs 0.01 0.01 0.01 0.01 0.01 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Net Cash Provided By Used In Investing Activities 5.00 15.00 5.00 -29.52 -0.06 -0.03 0.00 -0.01 -0.23 9.35 9.89 4.65 -0.14 -9.95 -15.15 3.98 5.13 9.48 4.69 -23.61 -0.76

Payments To Acquire Property Plant And Equipment NA NA 0.00 0.08 0.07 0.03 0.00 0.01 0.25 0.65 0.11 0.35 NA NA 0.01 0.02 0.00 0.02 0.12 0.30 0.76

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Net Cash Provided By Used In Financing Activities 2.10 0.39 27.40 -0.01 11.11 15.16 7.38 0.35 10.67 0.83 0.24 15.01 43.32 0.04 34.49 12.29 3.75 0.26 4.17 NA NA

Payments For Repurchase Of Common Stock NA NA -0.00 0.01 0.00 0.19 0.18 0.48 0.00 0.09 0.16 0.04 NA NA NA NA NA NA NA NA NA

2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30

Revenues 1.38 0.19 0.15 0.07 0.03 1.00 8.25 2.40 2.74 1.55 0.48 0.70 1.07 0.90 1.05 0.98 1.05 0.37 0.33 0.45 0.17

L G Chem Life Sciences, Collaboration Agreement With L G Chem Life Sciences 0.03 0.04 0.15 68.00 0.03 1.00 7.86 2.10 2.04 0.79 0.52 0.65 0.96 0.84 1.05 0.81 0.72 0.00 NA NA 0.00

Merck, Collaboration Agreement With Merck NA NA 0.00 0.00 0.00 0.00 0.39 0.29 0.70 0.77 -0.05 0.05 0.12 0.06 0.00 0.17 0.33 0.37 0.33 0.45 0.17

Ono Collaboration And Option Agreement 1.35 0.15 NA NA 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Revenue From Contract With Customer Excluding Assessed Tax 1.38 0.19 0.15 0.07 0.03 1.00 8.25 2.40 2.74 1.55 0.48 0.70 1.07 0.90 1.05 0.98 1.05 0.37 0.33 0.45 0.17

L G Chem Life Sciences, Collaboration Agreement With L G Chem Life Sciences 0.03 0.04 0.15 68.00 0.03 1.00 7.86 2.10 2.04 0.79 0.52 0.65 0.96 0.84 1.05 0.81 0.72 0.00 NA NA 0.00

Merck, Collaboration Agreement With Merck NA NA 0.00 0.00 0.00 0.00 0.39 0.29 0.70 0.77 -0.05 0.05 0.12 0.06 0.00 0.17 0.33 0.37 0.33 0.45 0.17

Ono Collaboration And Option Agreement 1.35 0.15 NA NA 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Plots across concepts

IncomeStatement

Operating Income Loss

Expenses

Interest Expense

Balance Sheet

Long Term Debt

Assets

Property Plant And Equipment Net

Current Assets

Accounts Receivable Net Current

NonCurrent Assets

Other Assets Noncurrent

PropertyPlantAndEquipmentNet

Property Plant And Equipment Net

Liabilities

Operating Lease Liability

Current Liabilities

Accounts Payable Current

Noncurrent Liabilities

Operating Lease Liability Noncurrent

Stockholders Equity

Retained Earnings Accumulated Deficit

CashFlow

Net Income Loss

NetCashProvidedByUsedInOperatingActivities

Net Income Loss

NetCashProvidedByUsedInInvestingActivities

Payments To Acquire Property Plant And Equipment

NetCashProvidedByUsedInFinancingActivities

Payments For Repurchase Of Common Stock

OperatingLeaseLiability

Operating Lease Liability Current

NonoperatingIncomeExpense

Nonoperating Income Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Undiscounted Excess Amount

Line plots across dimensions of each concept

TTM Greenblatt ROC
_
(None,)

T T M Greenblatt R O C_

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)

Allocated Share Based Compensation Expenseus-gaap: Income Statement Location

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)

Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:StatementEquityComponents
(None,)

Stock Issued During Period Value New Issuesus-gaap: Statement Equity Components